5mg/dose x 112 doses.
Properties
This product is a colorless or slight yellow suspension, stored in a Pressure vessel with a quantitative valve system.

Pharmacological Effects
This product can selectively inhibit the release of allergic transmitter induced by antigen-antibody combination, thus preventing or relieving spasm of bronchial smooth muscle, and symptoms of increased vessel permeability and mucous edema.

It can be effectively absorbed by the lungs, and eliminated from the body in urine and bile. The effect may last 6 hours with no accumulative action.

Indications
Bronchial asthma, especially that induced by extrinsic allergens, and allergic rhinitis.